AG-73305 Single Ascending Dose Cohort Study in DME
Status:
Not yet recruiting
Trial end date:
2023-10-15
Target enrollment:
Participant gender:
Summary
This is a multi-centered, open-labeled, single ascending-dose-cohort study to evaluate 4
dosing cohorts of AG-73305 administered by intravitreal injection in patients with diabetic
macular edema (DME).